Covered recipient · General Payments record
LAURANCE W CHOATE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$602.07
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $247.37 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $116.28 | 5 |
| GlaxoSmithKline, LLC. | $29.96 | 1 |
| Indivior Inc. | $28.15 | 1 |
| Amgen Inc. | $22.50 | 1 |
| Axsome Therapeutics, Inc. | $19.14 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.59 | 1 |
| Lilly USA, LLC | $13.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.15 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103464234 | CMS |
| ABBVIE INC. | $21.40 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103464236 | CMS |
| ABBVIE INC. | $27.64 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103464238 | CMS |
| ABBVIE INC. | $32.82 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103464240 | CMS |
| ABBVIE INC. | $20.27 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103464242 | CMS |
| Amgen Inc. | $22.50 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117223634 | CMS |
| Axsome Therapeutics, Inc. | $19.14 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148298078 | CMS |
| GlaxoSmithKline, LLC. | $29.96 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116031234 | CMS |
| Indivior Inc. | $28.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144525934 | CMS |
| Lilly USA, LLC | $13.75 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135147314 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.59 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118875738 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.